Literature DB >> 14512588

Infectious diseases. Singapore lab faulted in SARS case.

Martin Enserink.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14512588     DOI： 10.1126/science.301.5641.1824b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).

Authors:  Shixia Wang; Pavlo Sakhatskyy; Te-Hui W Chou; Shan Lu
Journal:  J Immunol Methods       Date:  2005-04-25       Impact factor: 2.303

Review 3.  Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review.

Authors:  Etienne Decroly; Jacques van Helden; Erwan Sallard; José Halloy; Didier Casane
Journal:  Environ Chem Lett       Date:  2021-02-04       Impact factor: 13.615

Review 4.  COVID-19 is a natural infectious disease.

Authors:  Zhenjun Li; Jiafu Jiang; Yigang Tong; Xiangdong Ruan; Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2021-12-11

5.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.

Authors:  Yanqing Ding; Li He; Qingling Zhang; Zhongxi Huang; Xiaoyan Che; Jinlin Hou; Huijun Wang; Hong Shen; Liwen Qiu; Zhuguo Li; Jian Geng; Junjie Cai; Huixia Han; Xin Li; Wei Kang; Desheng Weng; Ping Liang; Shibo Jiang
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

Review 6.  Emerging viral infections.

Authors:  John R Su
Journal:  Clin Lab Med       Date:  2004-09       Impact factor: 1.935
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.